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The biochemical properties and immunohistochemical lo-
calization of leukotriene (L T) A4 hydrolase were investigated 
in human skin. The activity of L T A4 hydrolase, which cata-
lyzes the hydrolysis of LT A4 to LTB4, the most chemotactic 
compound known, was detected in the 100,000 X g superna-
tant of homogenates of human epidermis and a transformed 
epidermal cell line (H~C-l). No significa~t LTA4 hy?rolase 
activity was detected m human whole skm or derrrus. The 
enzymatic properties of LTA4 hydrolase isolated from 
human keratinocytes and peripheral leukocytes were similar. 
Their activities were inhibited by bestatin and captopril. and 
they were completely absorbed by anti-human L T A4 hydro-
lase antibody. By immunoblotting analysis using this anti-
L eukotriene (LT) B4 is one of the most potent mediators ofleukocyte chemotaxis and smooth muscle contraction [1.2]. LTB4• through binding to receptors. stimulates neutrophil activities such as chemokinesis. aggregation. degranulation. adhesion to endothelium. etc. Intrader-
mal injection of L TB4 causes local edema and vasoconstriction in 
human skin [3.4]. Furthermore. keratinocytes. which possess spe-
cific binding sites for L TB4• may be a target for its proliferative 
action [5 - 7]. LTB4 can also induce pigmentation in human mel a-
nocytes [8.9]. Therefore. L ~B4 has b.een s.uspected to play an impo:-
tant role in the pathogeneSIs of various lllflammatory and allergiC 
diseases, including skin diseases such as psoriasis or atopic dermatitis 
[10-13]. . . . . .. 
LTB4 is formed from L T A4• which IS a pivotalllltermedlate III the 
biosynthesis of other leukotrienes [14.15]. LTA4 is formed from 
5-HPETE. a 5-lipoxygenase product of arachidonic acid. Conver-
sion ofLTA4 to LTB4 is catalyzed by LTA4 hydrolase, which is the 
rate-limiting enzyme for LTB4 biosynthesis. LTA4 hydrolase, re-
ported to be ubiquitously distributed [1 6.17]. is found in large 
amounts in blood cells. such as human leukocytes [18], human 
erythrocytes [19]. and rat neutrophils [20]. Guinea pig lung and 
liver and human liver [21.22] and blood plasma [23] also possess this 
enzyme. Recently, LTA4 hydrolase has been recognized as a 
Zn++-metallohydrolase possessing intrinsic amino-peptidase activ-
ity [24-26]. and its enzyme activity is inhibited by bestatin or cap-
topril, which are inhibitors of aminopeptidase [25,26]. Human 
LTA4 hydrolase eDNA has been cloned and expressed in Escherichia 
coli as an active fusion protein [27]. Although it has been reported 
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body, LTA4 hydrolase was detected as a 70-kDa protein in 
human epidermis and HSC-l and was found to be similar to 
the enzyme detected in peripheral mononuclear leukocytes. 
In human dermis, LT A4 hydrolase was barely detected by 
Western blotting. On the other hand, L T A4 hydrolase was 
demonstrated in the cytoplasm of keratinocytes in the epi-
dermis, and in fibroblasts, infiltrating and endothelial cells in 
the dermis of normal human skin by immunohistochemical 
analysis using the immunoperoxidase method. These results 
suggest that L TB4 can be generated from LT A4 by LT A4 
hydrolase in keratinocytes as well as fibroblasts, infiltrating 
and endothelial cells in the dermis of human skin. ] Invest 
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that human skin can synthesize LTB4, LTC4, and LTD4 from ara-
chidonic acid [28,29], the details of LTB4 biosynthesis in the epi-
derrnis have not been definitely established. To clarify this issue, we 
investigated the enzymatic properties and immunohistochemical 
localization of LTA4 hydrolase in human skin. Such studies should 
provide a better understanding of the pathophysiologic role of 
L TB4 and may identify new targets for pharmacologic manipula-
tion. thus leading to new strategies for the treatment of various skin 
diseases. 
MATERIALS AND METHODS 
Materials Methyl ester ofLTA. was supplied by Ono Pharmaceutical Co. 
(Osaka. Japan). LTB. and prostaglandin (PG) B2 were purchased from Cay-
man Chemical Co. (Ann Arbor. MI). Bestatin [(2S. 3R)-3-amino-2-hy-
droxy-4-phenylbutanoyl-L-leucine) and captopril [(2S)-1-(3-mercapto-2-
methyl-propionyl)-L-proline) were supplied by Sigma (St. Louis. MO). 
Eicosapentaenoic acid (EPA) was obtained from Mochida Pharmaceutical 
Co. (Tokyo. Japan). Docosahexaenoic acid (DHA) was obtained from Sa-
gami Chemical Research Center (Sagamihara. Japan). Antibody against 
human LT A. hydrolase antibody (17] was supplied by Prof. T. Shimizu 
(Second Department of Biochemistry. Faculty of Medicine, University of 
Tokyo). Vectastain avidin-biotin-peroxidase complex kit was obtained 
from Vector Laboratories (Burlingame, CAl. Polymorphonuclear leuko-
cytes and mononuclear leukocytes were separated from heparinized human 
peripheral blood by the method of Ferrante et of (30). Normal human skin 
was obtained from surgical specimens. and then epidermis was isolated from 
dermis by a sequence of trypsinization and separation. Primary cultured 
human keratinocytes from neonatal foreskins were purchased from Clone-
tics Co. (San Diego. CAl. Transformed human keratinocyte cell line 
HSC-1. originally derived from human squamous cell carcinoma. was sup-
plied by Prof. S. Kondo (Department of Dermatology, Yamagata University 
School of Medicine. Japan) (31). All other reagents were of analytical grade 
and used without further purification. 
Assay ofLTA. Hydrolase LTA. hydrolase activity was measured as de-
scribed previously [17.32)' The lithium salt of LTA. was prepared from the 
methyl ester ofLTA. by saponification in a mixture oftetrallydrofuran and 
lithium hydroxide in water. After evaporation under a stream of nitrogen. 
LTA. was dissolved in an ethanol-water mixture. The concentration of 
LTA. was calculated from UV absorption at 280 nm (e = 40.000 (32)). The 
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standard reaction mixture (50/11) contained the enzyme in 0.1 M Tris-HCI 
buffer (pH 7.8). After preincubation at 37°C for 1 min, LTA .. (an ethanol-
water solution, containing some lithium hydroxide) was added to a final 
concentration of 80 /1M. After a 3 min incubation at 37°C, 100/11 of stop-
ping solution [acetonitrile/methanol/acetic acid (150/50/3, v/v) contain-
ing 0.3 nmol of PGB2 as an internal standardJ was added. The mixture was 
kept at -20°C for 30 min and then centrifuged at 10,000 X g for 5 min at 
4°C. A 120-/11 aliquot of the supernatant was added to 20/11 of 0.35% 
ethylenediaminetetraacetic acid (EOTA), and 50/11 of this solution (140/11) 
was injected onto a reverse-phase high-performance liquid chromatograph 
(HPLC) (655A-ll, Hitachi, Tokyo, Japan). The column (TSK OOS-
80TM, 5 /1m, Toyosoda, Tokyo, Japan, 0.46 X 15 em) was eluted with 
solvent (acetonitrile/methanol/water/acetic acid (300/100/300/0.6 v/v) 
containing 0.05% EOTA) at a flow rate of 1 ml/min at a room temperature. 
The absorbance at 270 nm was monitored, and the amount of L TB .. formed 
was calculated from the peak-area ratio L TB .. /PGB2 by using a data-process-
ing system (0-2000, Hitachi, Tokyo, Japan). For each enzyme source, three 
separate incubations were carried out with different volumes of enzyme 
solutions. Linear correlations of the amounts of L TB .. formed versus the 
amounts of enzyme added were obtained. Specific activities were expressed 
as nmol of LTB .. /mg of protein/min, or pmol/cell number/min. Protein 
concentrations were determined by the method of Lowry et a1 [33J using 
bovine serum albumin as a standard. 
Immunochemical Study In immunotitration analyses, the 100,000 X g 
supernatants ofHSC-l cells or human peripheral leukocytes (approximately 
80% polymorphonuclear leukocytes, 20% mononuclear leukocytes) were 
incubated overnight at 4 ° C with various amounts of antibody against human 
LTA .. hydrolase [17J. After incubation with each antibody, the reaction 
mixture was centrifuged at 10,000 X g for 10 min, and the resulting super-
natant was recovered for the determination of LT A .. hydrolase activity. 
Western Blotting Analysis The 100,000 X g supernatants of various 
human skin preparations were precipitated with 0.2 mI of20% trichloroace-
tic acid and washed three times with 0.2 mI of the same solution. The 
precipitates were solubilized with 0.1 ml of 1 N NaOH, and their protein 
contents were measured by the method of Lowry et a1 [33J. Samples 
(10 /1g protein) were subjected to 12% sodium dodecyl sulfate (SOS) -
polyacrylamide gel electrophoresis by the method ofLaemmli [34]. Proteins 
separated in the gels were transferred to nitrocellulose paper and processed 
for Western blotting [35J using anti-human L T A .. hydrolase antibody. 
Immunohistochemical Staining Normal human skin was excised, cut 
into small blocks, and fixed in 4% (w Iv) paraformaldehyde in 0.1 M sodium 
phosphate buffer (pH 7.4) for 15 h at 4 ° C, followed by successive washings 
with 10, 15, and 20% (w/v) sucrose in 10 mM sodium phosphate-buffered 
saline (PBS) (pH 7.4) as described previously [17J. Tissue blocks were placed 
in OCT compound and frozen in dry ice/acetone. Tissue blocks were then 
sliced into 6-/1m sections in a cryostat and mounted on ovalbumin-coated 
glass slides. After being immersed in 5% normal goat serum for 1 h at a room 
temperature, sections were stained by the method of Hsu et al [36J using 
anti-human LTA .. hydrolase antiserum (diluted 1/500 in PBS) as the first 
antibody, biotinylated anti-rabbit IgG antibody as the second labeled anti-
body, and a soluble avidin-biotin-complex (Vectastain ABC Kit) . The con-
trol sections were stained with nonimmunized rabbit serum as the first 
reagent. Sections were then reacted with a diaminobenzidine-hydrogen per-
oxide solution for 30 min. 
RESULTS 
LTA. Hydrolase Activity in Human Skin L T A4 hydrolase ac-
tivity was found in the supernatant fraction (100,000 X g, 1 h) in 
normal human epidermis and transformed cultured keratinocytes 
(HSC-l cells) (Table I). Human epidermis showed significant but 
low LTA4 hydrolase activity (0.16 ± 0.03 nmol/min/mg protein), 
when compared to guinea pig lung (0.81 ± 0.21 nmol/min/mg 
protein) or small intestine (0.85 ± 0.23 nmol/min/mg protein) 
(data not shown). In contrast, human whole skin and dermis 
showed no significant LTA4 hydrolase activity (data not shown). 
HSC-l cells had a higher enzyme activity ofLT A4 hydrolase per 106 
cells than peripheral leukocytes (Table I). It is concluded that epi-
dermal keratinocytes themselves possess L TA4 hydrolase because 
HSC-l ceJls showed L T A4 hydrolase activity. 
Inhibition of LTA. Hydrolase Activity by Various Com-
pounds Inhibition of LTA4 hydrolase in supernatants 
(100,000 X g, 1 h) ofHSC-l cells by various compounds was exam-
ined. Bestatin at 50 11M and captopril at 200 11M reduced the forma-
THE JOURNAL OF INVESTIGATIVE DERMATOLOGY 
Table I. LTA4 Hydrolase Activity in Human Skin 
and Peripheral Leukocytes' 
Tissue 
Specific Activity 
(pmol/miu/l06 
cells) 
(nmol/min/mg 
protein) 
Normal epidermis 0.16 ± 0.03 
0.11 ± 0.02 
0.21 ± 0.04 
0.12 ± 0.03 
HSC-l cells 
Polymorphonuclear leukocytes 
Mononuclear leukocytes 
27.6 ± 5.4 
17.5 ± 3.5 
11.4±2.9 
• Values are expressed as the mean ± SD of three experiments. Ell2yme preparation 
procedures (100,000 X g, 1 h, supernatant) and the LTA. hyd.rolase assay arc deScribed 
in Materials arid Methods. 
tion of LTB4 by 50% (Fig 1). In contrast, EPA and DHA did not 
inhibit the production of LTB4. Similar degrees of inhibition Were 
observed with these compounds when L T A4 hydrolase was isolated 
from human peripheral leukocytes (data not shown). 
Immunochemical Properties ofLTA. Hydrolase in Human 
Skin In immunotitration analyses with the antibody against 
L TA4 hydrolase, the activities in HSC-l cells and human peripheral 
leukocytes showed identical titration curves (Fig 2). An excess of 
anti-L T A4 hydrolase antibody completely eliminated enzyme ac-
tivity, whereas a nonimmunized IgG had no effect. 
Immunoblotting Analysis of LTA .. Hydrolase in Human 
Skin With immunoblotting analysis, L T A4 hydrolase in normal 
human mononuclear leukocytes (Fig 3, lane 1), transformed human 
epidermal cell line (HSC-l) (Fig 3, lane 2), human primary cultured 
keratinocytes (Fig 3, lane 3) and normal human epidermis (Fig 3, 
lane 4) were precipitated as a 70-kDa protein. LT A4 hydrolase Was 
not detected by Western blotting in human whole skin (Fig 3, 
lane 5) and the dermis (Fig 3, lane 6). As for human polymorphonu_ 
clear leukocytes the protein band at 70-kDa and a few low -
molecular-weight protein bands were visible (data not shown). The 
extra bands may be due to proteolytic degradation of the enzyme in 
polymorphonuclear leukocytes. 
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Figure 1. Inhibition ofLTA .. hydrolase in supernatants (100,000 X g, 1 h) 
ofHSC-l cells by various compounds. LTA. hydrolase activity, which Was 
assayed as described in Materials and Met/lods, was inhibited by increasing 
concentrations of bestatin (.&) and captopril (e). In contrast, EPA (0) and 
OHA (6) showed no effect on the production ofLTA ... Each point repre-
sents the mean ± SE of measurements performed in triplicate. 
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Figure 2. Immunotitration analyses ofL TA. hydrolase activiry in superna-
tants (100,000 X g, 1 h) of HSC-1 cells and human peripheral leukocytes 
using an antibody against human L T A. hydrolase. After incubation of super-
natants containing a given activiry of LTA. hydrolase and various amounts 
of antibody at 4 0 C overnight, the residual activiry was determined as de-
scribed in Materials alld Methods. The percentage of remaining activiry rela-
tive to that before incubation is shown for HSC-1 (.6.) and leukocytes (e ) 
incubated with anti-LTA. hydrolase IgG, and HSC-1 (~) and leukocytes 
(0) incubated with nonimmunized IgG. Each point represents the mean ± 
SE of measurements performed in triplicate. 
hnnlUnohistochemical Distribution of LTA. Hydrolase in 
Human Skin LTA4 hydrolase was demonstrated immunohisto-
chemically in the cytoplasm of epidermal cells (Fig 4A) . In the 
dermis, fibroblasts (arrows) , infiltrating cells, and endothelial cells 
(arrowheads) also stained pos.itively ~Fig 4!3) . No .specifi~ immun~­
staining was observed upon l11cubatlon with nommmumzed rabbit 
serum (Fig 4C). 
DISCUSSION 
LTB4, which promotes leukocyte chemotaxis and smooth muscle 
contraction, is found in significant amounts in lesional skin of psori-
atic patients and in the skin and serum of atopic dermatitis patients 
[10- 13]. Therefore, L TB4 is suspected to playa significant role as a 
mediator in the pathogenesis of atopic dermatitis, psoriasis, and 
other inflammatory and allergic skin diseases. L TB4 is formed from 
L T A4, which is a pivotal intermediate in the biosynthesis of other 
MWX 10-3 
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leukotrienes [14,15). Despite a number of investigations, the actual 
cellular origin of L TB4 in skin lesions has not been definitively 
established. We tried to answer this question by focusing on human 
skin LTA4 hydrolase, the enzyme that catalyzes the conversion of 
LTA4 to LTB4. In our study, we repeated each experiment at least 
truee times, and obtained the same results each time. Based on our 
results with immunoabsorption (Fig 2) and immunoblotting (Fig 
3), human epidermal keratinocytes clearly showed LTA4 hydrolase 
activity; the LT A4 hydrolase was also shown to be identical to the 
enzyme found in peripheral leukocytes. The immunoabsorption 
test (Fig 2) also demonstrated that the conversion of L T A4 to L TB4 
is catalyzed only by LTA4 hydrolase. Some authors claim that epi-
dermal cells can generate L TB4 from arachidonic acid [28,29]' How-
ever, these studies are hampered by the problem of cellular hetero-
geneity because preparations ofkeratinocytes obtained from human 
or animals usually contain Langerhans cells or melanocytes. In 
previous studies [37,38], we found that rat epidermis possesses po-
tent PGD synthetase activity, but none was detected in keratino-
cytes. An immunohistochemical study demonstrated that Langer-
hans cells in epidermis, but not in keratinocytes, showed active 
PGD synthetase [37]. To confirm that keratinocytes can synthesize 
LTB4 from arachidonic acid requires a homogenous preparation of 
keratinocytes. Some authors claim that pure keratinocytes have 
weak but significant 5-lipoxygenase activity for the generation of 
LTA4 from arachidonic acid [28 ,29]. In contrast, Sola et al [39] and 
Iversen et a1 [40] recently reported that pure keratinocytes cannot 
produce L TB4 from arachidonic acid. We did not determine if hu-
man keratinocytes have 5-lipoxygenase activity for the generation 
of L TA4 from arachidonic acid . Recently, several reports have sug-
gested that some kinds of cells lack 5-lipo>.J'genase activity but that 
they possess LTA4 hydrolase activity [41-44]. In these cells, LTB4 
can be converted from LTA4 by LTA4 hydrolase but LTA4, a sub-
strate, must be transferred from other cells such as neutrophils, 
which show 5-lipoxygenase activity. For example, LTA. is trans-
ferred from neutrophils or macrophages to lymphocytes, endothe-
lial cells, or erythrocytes [19,41-43] for subsequent generation of 
LTB4. In the skin, Sola et al [39] and Iversen et of [40] suggest that 
keratinocytes generate LTB4 using LTA4, which is obtained from 
neutrophils in the dermis. Although we did not specifica.lly address 
this question, our study has confirmed that human keratinocytes 
possess LT A4 hydrolase al though the source of LT A4 is not known. 
From immunohistochemical studies, keratinocytes, endothelial 
cells, and fibroblasts all contain LTA4 hydrolase (Fig 4) . These re-
sults agree with reports that L TA4 hydrolase shows a ubiquitous 
distribution in various organs of guinea pigs [16,17). Furthermore, 
it has been demonstrated that endothelial cells [41] and fibroblasts 
[43] as well as leukocytes have active LTA4 hydrolases. However, 
neither the enzyme assay nor Western blotting analysis could reveal 
the enzyme activity in the total dermis. LT A4 hydrolase in these 
1 2 3 4 5 6 
Figure 3. Immunoblot analysis using anti-LTA. hydro-
lase IgG. Supernatants (100,000 X g, 1 h; 10 I1g protein in 
each lane) of various human skin preparations were sepa-
rated on 12% 5DS-polyacrylamide gel and electropho-
retically transferred to a nitrocellulose membrane. Then 
proteins were immunostained using anti-LTA. hydrolase 
IgG. Lane 1, human peripheral mononuclear cells; lane 2, 
HSC-1 cells; lane 3, human primary cultured epidermal 
cells; latle 4, normal human epidermis; lane 5, normal 
human whole skin; and lotte 6, normal human dermis. 
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Figure 4. Immunohistochemical distribution of L T A. hydrolase in normal 
human skin as revealed with an irnmunoperoxidase method using antiserum 
against human L T A. hydrolase. A) Cytoplasmic distribution of L T A. hy-
drolase was demonstrated in the epidermal keratinocytes. B) In the dermis. 
infiltrating cells. fibroblasts (arrows) and endothelial cells (arrowheads) were 
stained. C) No specific immunostaining was observed after incubation with 
nonimmunized rabbit serum. Bar, 10 /-Lm. 
cells may participate only in a small portion in total dermis. and the 
enzyme activity would be below the limit of detection of our mea-
surements. If more sensitive measurements were possible. we would 
expect to detect L T A. hydrolase activity. Furthermore. enzyme 
activity of LTA. hydrolase was not detected in primary cultured 
human keratinocytes in our experiment. This was due to the small 
sample size. which made the activity below the limit of detection. 
Currently. we are trying to more precisely determine the localiza-
tion of this enzyme using immunoelectron microscopy. 
L T A. hydrolase is a bifunctional enzyme with Zn++ -metallohy-
drolase and aminopeptidase activities [24-26]. We showed that 
bestatin and captopril. which are inhibitors of aminopeptidase 
[25.26]. inhibited the LTA. hydrolase activities in human epidermis 
(Fig 1) and peripheral leukocytes. Because bestatin and captopril are 
already being used in the treatment of various diseases such as lym-
phoma. leukemia. and hypertension without serious side effects. it 
may be worthwhile to try to use these drugs in the treatment of 
psoriasis or atopic dermatitis. which are chronic and difficult skin 
diseases to treat. 
On the other hand. polyunsaturated fatty acids such as EPA are 
reported to be effective in the treatment of psoriasis and atopic 
dermatitis [45.46]. However. our results (Fig 1) showed that EPA 
and DHA did not inhibit LTA. hydrolase activity. although these 
polyunsaturated fatty acids inhibit the generation ofLTB. in intact 
cell system [47]. EPA and DHA. which compete with arachidonic 
acid. are metabolized by 5-lipoxygenase and LTA. hydrolase to 
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LTBs. which has much less biologic activity than LTB. [48,49]. 
Therefore. the results shown in Fig 1 are quite reasonable. 
In preliminary studies we have found L T A. hydrolase activity is 
increased in the peripheral leukocytes of some patients with psoria-
sis or atopic dermatitis. Therefore. a useful therapy may be to con-
trol the L T A. hydrolase activity in patients with psoriasis or atopic 
dermatitis. 
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